Quoted from http://www.reuters.com/article/idUSTRE6424DA20100503
FDA probes risks of HIV, prostate, other drugs
Mon May 3, 2010 2:50pm EDT
WASHINGTON (Reuters) - Regulators are investigating potential risks from Abbott Laboratories Inc's HIV drug Kaletra, GlaxoSmithKline Plc's prostate drug Avodart and other medicines.
The agency also said it was investigating cases of male breast cancer in patients treated with Avodart as well as Merck & Co's prostate drug Proscar and baldness treatment Propecia.
The FDA releases a quarterly list of safety probes to inform the public about early investigations of potential side effects that have been reported. The list released on Monday covered issues identified between October and December 2009.
Being on the list does not mean the FDA has concluded the drug causes the specific risk, the agency said.
The FDA posted the list here